Canaccord Genuity Group Has Lowered Expectations for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPNGet Free Report) had its price objective dropped by analysts at Canaccord Genuity Group from $20.00 to $15.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the construction company’s stock. Canaccord Genuity Group’s price target would suggest a potential upside of 65.75% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the company. Seaport Res Ptn cut Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. Roth Mkm lowered their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Barclays lowered their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. Finally, Craig Hallum lowered their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $26.33.

View Our Latest Report on ASPN

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $9.05 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels has a 52 week low of $8.43 and a 52 week high of $33.15. The stock has a market capitalization of $742.55 million, a P/E ratio of 905.91 and a beta of 2.14. The stock has a fifty day moving average of $12.36 and a 200-day moving average of $18.63.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, sell-side analysts expect that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC increased its stake in shares of Aspen Aerogels by 231.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 24,365 shares of the construction company’s stock valued at $289,000 after buying an additional 17,012 shares during the period. MetLife Investment Management LLC boosted its position in shares of Aspen Aerogels by 6.3% during the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock valued at $425,000 after purchasing an additional 2,118 shares in the last quarter. Mesirow Institutional Investment Management Inc. boosted its position in shares of Aspen Aerogels by 2.4% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 488,595 shares of the construction company’s stock valued at $5,805,000 after purchasing an additional 11,525 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Aspen Aerogels by 25.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company’s stock valued at $23,983,000 after purchasing an additional 409,862 shares in the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Aspen Aerogels by 78.4% during the 4th quarter. First Trust Advisors LP now owns 492,507 shares of the construction company’s stock valued at $5,851,000 after purchasing an additional 216,452 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.